CAPR Stock Drop Alert: Capricor Therapeutics Stock Plummets 64% after Clinical Data Issues Revealed – BFA Law Notifies Investors of the Imminent September 28 Deadline
A securities class action (Nkamga v. Capricor Therapeutics, No. 26-cv-04385) has been filed against Capricor in the U.S. District Court for the Southern District of California, with a lead plaintiff deadline of September 28, 2026.
Key figures
- Adcomm vote
- 9-3 against efficacy support
- Close july24
- 19.7
- Close july27
- 7
- Close july30
- 4.19
- Lead plaintiff deadline
- September 28, 2026
- Stock drop dollars july27
- $12.70
- Stock drop percent july27
- 64.5%
- Stock drop percent july30
- 36%
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.